维普中文期刊产品整合服务
126篇 您的检索式:作者名="Arcila"
    题名 作者 年代 出处 被引量
1Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations inlung adenocarcinomas otherwise negative for such alterations by othergenomic testing approaches 显示文摘Drilon A Wang L Arcila ME 2015Clin Cancer Res2015,21,16:1
2KIFSB-RET: Dis- covery of a novel fusion oncogene in lung adenocarcinomas by a systematic screen for tyrosine kinase fusions and identification of patients for a RET targeted therapy trial显示文摘Suehara Y Arcila ME Drilon AEDC 2012J Clin Oncol2012,30,15:1
3Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib显示文摘Oxnard GR Janjigian YY Arcila ME 0,,19:1
4Analysis of tumor specimens at the time of acquired resistance to EGFR- TKI therapy in 155 patients with EGFR-mutant lung cancers显示文摘Yu HA Arcila ME Rekhtman N 2013Clin Cancer Res2013,19,8:1
5EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics 显示文摘Arcila ME Nafa K Chaft JE 2013Mol Cancer Ther2013,12,2:1
6Clarifying the spec- trum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations显示文摘Rekhtman N Paik PK Arcila ME 2012Clin Cancer Res2012,18,4:1
7Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR显示文摘Brevet M Arcila M Ladanyi M 2010J Mol Diagn2010,12,2:1
8Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations显示文摘Paik PK Arcila ME Fara M 2011J Clin Oncol2011,29,15:1
9Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay显示文摘Arcila ME Oxnard GR Nafa K 0,,05:1
10Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer:Distinct natural history of patients with tumors harboring the T790M mutation显示文摘Oxnard GR Arcila ME Sima CS 0,,06:1
11Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIIOCA/AKT1 mutations显示文摘Rekhtman N Paik PK Arcila ME 2012C/in Cancer Res2012,18,4:1
12Identification ofKIF5B - RET and GOPC - ROS1 fusions in lung adeno-carcinomas through a comprehensive mRNA - basedscreen for tyrosine kinase fusions显示文摘Suehara Y Arcila M Wang L et ai 2012Clin Cancer Res2012,18,24:1
13Germline EG- FR T790M mutation found in multiple members of a fa- milial cohort显示文摘Yu HA Arcila ME Harlan Fleischut M 2014J Thorac Oncol2014,9,4:1
14Clinical characteristics of patients with lung adenocarcinomas harboring BRAF muta- tions显示文摘Paik PK Arcila ME Fara M 2011J ClinOncol2011,29,15:1
15Characteristics of lung cancers harboring NRAS mutations 显示文摘Ohashi K Sequist LV Arcila ME 2013Clin Cancer Res2013,19,9:1
16Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations 显示文摘Paik PK Arcila ME Fara M 2011J Clin Oncol2011,29,15:1
17HER2 amplification:a po- tential mechanism of acquired resistance to EGFR inhibition in EG- FR- mutant lung cancers that lack the second - site EGFR (T790M) mutation 显示文摘Takezawa K V Pirazzoli ME Arcila 2012Cancer Discovery2012,2,10:1
18Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1 显示文摘Ohashi K Sequist LV Arcila ME Proc Nat/ Acad Sci U S A0,109,31:1
19Ten case of ciguatera fish poisoning in Yucatanl显示文摘Arcila Herrera H Castello Navarrete A Mendoza Ayora J 1998Rev Invest Clin1998,50,2:1
20Prevalence, cliuicopatho- logic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenoearcinomas 显示文摘Arcila ME Chart JE Nafa K 2012Clin Cancer Res2012,18,18:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费